JP2020502111A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502111A5 JP2020502111A5 JP2019531649A JP2019531649A JP2020502111A5 JP 2020502111 A5 JP2020502111 A5 JP 2020502111A5 JP 2019531649 A JP2019531649 A JP 2019531649A JP 2019531649 A JP2019531649 A JP 2019531649A JP 2020502111 A5 JP2020502111 A5 JP 2020502111A5
- Authority
- JP
- Japan
- Prior art keywords
- oxy
- hydrogen
- indene
- hex
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2016-0171541 | 2016-12-15 | ||
| KR20160171541 | 2016-12-15 | ||
| KR10-2017-0171228 | 2017-12-13 | ||
| KR1020170171228A KR102007633B1 (ko) | 2016-12-15 | 2017-12-13 | 신규 페닐 프로피온 산 유도체 및 이의 용도 |
| PCT/KR2017/014757 WO2018111012A1 (en) | 2016-12-15 | 2017-12-14 | Novel phenyl propionic acid derivatives and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020502111A JP2020502111A (ja) | 2020-01-23 |
| JP2020502111A5 true JP2020502111A5 (enExample) | 2020-11-12 |
| JP6892922B2 JP6892922B2 (ja) | 2021-06-23 |
Family
ID=62559593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531649A Expired - Fee Related JP6892922B2 (ja) | 2016-12-15 | 2017-12-14 | 新規フェニルプロピオン酸誘導体及びその用途 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US11225472B2 (enExample) |
| EP (1) | EP3555076B1 (enExample) |
| JP (1) | JP6892922B2 (enExample) |
| KR (1) | KR102007633B1 (enExample) |
| CN (1) | CN110049984B (enExample) |
| AU (1) | AU2017374460B2 (enExample) |
| BR (1) | BR112019012433A2 (enExample) |
| CA (1) | CA3042528C (enExample) |
| DK (1) | DK3555076T3 (enExample) |
| ES (1) | ES2948485T3 (enExample) |
| FI (1) | FI3555076T3 (enExample) |
| HU (1) | HUE062468T2 (enExample) |
| IL (1) | IL267239B (enExample) |
| MX (1) | MX2019007071A (enExample) |
| MY (1) | MY198292A (enExample) |
| PH (1) | PH12019501251A1 (enExample) |
| PL (1) | PL3555076T3 (enExample) |
| PT (1) | PT3555076T (enExample) |
| RS (1) | RS64259B1 (enExample) |
| RU (1) | RU2760266C2 (enExample) |
| SI (1) | SI3555076T1 (enExample) |
| WO (1) | WO2018111012A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220112185A1 (en) * | 2016-12-15 | 2022-04-14 | Ildong Pharmaceutical Co., Ltd. | Novel phenyl propionic acid derivatives and uses thereof |
| KR102007633B1 (ko) * | 2016-12-15 | 2019-08-06 | 일동제약(주) | 신규 페닐 프로피온 산 유도체 및 이의 용도 |
| WO2019160882A1 (en) | 2018-02-13 | 2019-08-22 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| WO2019191624A1 (en) | 2018-03-29 | 2019-10-03 | Arbutus Biopharma, Inc. | Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same |
| WO2019204609A1 (en) | 2018-04-19 | 2019-10-24 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| BR112020026746A2 (pt) | 2018-07-13 | 2021-03-30 | Gilead Sciences, Inc. | Composto, composição farmacêutica, métodos para inibir pd-1, pd-l1 e/ou a interação de pd-1/pd-l1 e para tratar câncer, e, kit para tratar ou prevenir câncer ou uma doença ou condição. |
| CN112955435B (zh) | 2018-10-24 | 2024-09-06 | 吉利德科学公司 | Pd-1/pd-l1抑制剂 |
| JP2022552655A (ja) | 2019-10-07 | 2022-12-19 | キャリーオペ，インク． | Ｇｐｒ１１９アゴニスト |
| PH12022552277A1 (en) | 2020-02-28 | 2024-03-04 | Kallyope Inc | Gpr40 agonists |
| JP2023526625A (ja) | 2020-05-19 | 2023-06-22 | キャリーオペ，インク． | Ａｍｐｋアクチベーター |
| CN116390925A (zh) | 2020-06-26 | 2023-07-04 | 卡尔优普公司 | Ampk活化剂 |
| EP4329756A1 (en) * | 2021-04-29 | 2024-03-06 | Ildong Pharmaceutical Co., Ltd. | Pharmaceutical composition comprising gpr40 agonist and sglt-2 inhibitor |
| WO2022269439A1 (en) * | 2021-06-21 | 2022-12-29 | Ildong Pharmaceutical Co., Ltd. | Method of controlling blood sugar level and treatment of diabetes and related conditions |
| WO2023080299A1 (ko) * | 2021-11-08 | 2023-05-11 | 일동제약(주) | 페닐 프로피온 산 유도체의 신규 염, 이의 제조 방법 및 이를 포함하는 약학 조성물 |
| KR20240084229A (ko) * | 2022-12-06 | 2024-06-13 | 유노비아 주식회사 | 안정성이 향상된 gpr40 효현제를 유효성분으로 포함하는 약제학적 조성물 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4594611B2 (ja) * | 2002-11-08 | 2010-12-08 | 武田薬品工業株式会社 | 受容体機能調節剤 |
| EA011010B1 (ru) * | 2004-02-27 | 2008-12-30 | Эмджен, Инк. | Соединения, модулирующие рецептор gpr40, фармацевтическая композиция, способ лечения заболеваний, чувствительных к модулированию рецептора gpr40 (варианты), способ модулирования функции gpr40 (варианты) и способ модулирования циркулирующей концентрации инсулина |
| EP1726580A4 (en) * | 2004-03-15 | 2008-02-13 | Takeda Pharmaceutical | AMINOPHNYLPROPANO ACID DERIVATIVE |
| CA2620476A1 (en) * | 2005-06-02 | 2006-12-07 | Jenrin Discovery | Mao-b inhibitors useful for treating obesity |
| WO2007033002A1 (en) * | 2005-09-14 | 2007-03-22 | Amgen Inc. | Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| JP5055852B2 (ja) | 2006-06-21 | 2012-10-24 | 住友大阪セメント株式会社 | 鉄資源の回収方法 |
| HUE025363T2 (en) * | 2010-12-01 | 2016-02-29 | Boehringer Ingelheim Int | Indanyl Oxide Hydrobenzofuranylacetic Acids that can be used to treat metabolic syndrome |
| JP2013147443A (ja) * | 2012-01-18 | 2013-08-01 | Daiichi Sankyo Co Ltd | β置換カルボン酸誘導体 |
| US8633182B2 (en) | 2012-05-30 | 2014-01-21 | Boehringer Ingelheim International Gmbh | Indanyloxyphenylcyclopropanecarboxylic acids |
| JP6533778B2 (ja) * | 2013-09-26 | 2019-06-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｇｐｒ４０アゴニストとしてのインダニルオキシジヒドロベンゾフラニル酢酸誘導体を調製するための方法および中間体 |
| WO2017180457A1 (en) | 2016-04-11 | 2017-10-19 | Janssen Pharmaceutica Nv | Gpr40 agonists in anti-diabetic drug combinations |
| KR102007633B1 (ko) * | 2016-12-15 | 2019-08-06 | 일동제약(주) | 신규 페닐 프로피온 산 유도체 및 이의 용도 |
| US20220112185A1 (en) * | 2016-12-15 | 2022-04-14 | Ildong Pharmaceutical Co., Ltd. | Novel phenyl propionic acid derivatives and uses thereof |
| EP4329756A1 (en) * | 2021-04-29 | 2024-03-06 | Ildong Pharmaceutical Co., Ltd. | Pharmaceutical composition comprising gpr40 agonist and sglt-2 inhibitor |
| WO2022269439A1 (en) * | 2021-06-21 | 2022-12-29 | Ildong Pharmaceutical Co., Ltd. | Method of controlling blood sugar level and treatment of diabetes and related conditions |
| US20230022803A1 (en) * | 2021-06-25 | 2023-01-26 | Ildong Pharmaceutical Co., Ltd. | Novel crystalline form of gpr40 agonist |
-
2017
- 2017-12-13 KR KR1020170171228A patent/KR102007633B1/ko active Active
- 2017-12-14 SI SI201731367T patent/SI3555076T1/sl unknown
- 2017-12-14 CA CA3042528A patent/CA3042528C/en active Active
- 2017-12-14 HU HUE17880872A patent/HUE062468T2/hu unknown
- 2017-12-14 DK DK17880872.1T patent/DK3555076T3/da active
- 2017-12-14 RU RU2019121871A patent/RU2760266C2/ru active
- 2017-12-14 WO PCT/KR2017/014757 patent/WO2018111012A1/en not_active Ceased
- 2017-12-14 MX MX2019007071A patent/MX2019007071A/es unknown
- 2017-12-14 BR BR112019012433A patent/BR112019012433A2/pt not_active Application Discontinuation
- 2017-12-14 RS RS20230456A patent/RS64259B1/sr unknown
- 2017-12-14 FI FIEP17880872.1T patent/FI3555076T3/fi active
- 2017-12-14 US US16/467,654 patent/US11225472B2/en not_active Expired - Fee Related
- 2017-12-14 EP EP17880872.1A patent/EP3555076B1/en active Active
- 2017-12-14 PT PT178808721T patent/PT3555076T/pt unknown
- 2017-12-14 IL IL267239A patent/IL267239B/en unknown
- 2017-12-14 MY MYPI2019003388A patent/MY198292A/en unknown
- 2017-12-14 ES ES17880872T patent/ES2948485T3/es active Active
- 2017-12-14 JP JP2019531649A patent/JP6892922B2/ja not_active Expired - Fee Related
- 2017-12-14 CN CN201780074801.4A patent/CN110049984B/zh not_active Expired - Fee Related
- 2017-12-14 PL PL17880872.1T patent/PL3555076T3/pl unknown
- 2017-12-14 AU AU2017374460A patent/AU2017374460B2/en not_active Ceased
-
2019
- 2019-06-06 PH PH12019501251A patent/PH12019501251A1/en unknown
-
2021
- 2021-11-10 US US17/523,652 patent/US11731961B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020502111A5 (enExample) | ||
| RU2019121871A (ru) | Новые производные фенилпропионовой кислоты и их применение | |
| JP2007523155A5 (enExample) | ||
| JP2020075939A5 (enExample) | ||
| JP2017511329A5 (enExample) | ||
| JP2010520306A5 (enExample) | ||
| JP2012506381A5 (enExample) | ||
| JP2016535000A5 (enExample) | ||
| JP2011502958A5 (enExample) | ||
| JP2018535967A5 (enExample) | ||
| JP2016526540A5 (enExample) | ||
| JP2013517264A5 (enExample) | ||
| JP2003528095A5 (enExample) | ||
| JP2019505595A5 (enExample) | ||
| JP2018534288A5 (enExample) | ||
| RU2016102313A (ru) | Биарильные производные в качестве агонистов gpr120 | |
| JP2020527175A5 (enExample) | ||
| JP2014523400A5 (enExample) | ||
| RU2015100942A (ru) | Производное пиперидинилпиразолпиридина | |
| JP2009504792A5 (enExample) | ||
| RU2018131775A (ru) | 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета | |
| JP2015519322A5 (enExample) | ||
| JP2017536342A5 (enExample) | ||
| JP2020503293A5 (enExample) | ||
| JP2004524279A5 (enExample) |